Phase II study of pembrolizumab or pembrolizumab plus bevacizumab for recurrent glioblastoma (rGBM) patients

被引：34
|
作者：
Reardon, David A.
Nayak, Lakshmi
Peters, Katherine B.
Clarke, Jennifer Leigh
Jordan, Justin T.
De Groot, John Frederick
Nghiemphu, Phioanh Leia
Kaley, Thomas Joseph
Colman, Howard
Gaffey, Sarah C.
Caruso, Victoria
Debruyne, Myriam Bednarek
Bhavsar, Chinmay
Molinaro, Annette M.
Smith, Timothy
Severgnini, Mariano
Wen, Patrick Y.
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Duke Univ, Med Ctr, Durham, NC USA
[4] Univ Calif San Francisco, San Francisco, CA USA
[5] Massachusetts Gen Hosp, Boston, MA USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Neuro Oncol, Houston, TX USA
[7] Univ Calif Los Angeles, Los Angeles, CA USA
[8] Mem Sloan Kettering Canc Ctr, New York, NY USA
[9] Hunstman Canc Inst, Salt Lake City, UT USA
[10] Harvard Med Sch, Dana Farber, Brigham & Womens Canc Ctr, Boston, MA USA
[11] UC San Francisco, San Francisco, CA USA
[12] Brigham & Womens Hosp, Boston, MA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2006
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II AND BIOMARKER STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB FOR RECURRENT GLIOBLASTOMA PATIENTS
    Reardon, David
    Molinaro, Annette
    Peters, Katherine
    Clarke, Jennifer
    Jordan, Justin
    de Groot, John
    Nghiemphu, Phioanh
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Smith, Timothy
    Cote, David
    Severgnini, Mariano
    Yearley, Jennifer
    Zhao, Qing
    Blumenschein, Wendy
    Duda, Gabriel
    Muzikansky, Alona
    Jain, Rakesh
    Wen, Patrick
    Nayak, Lakshmi
    NEURO-ONCOLOGY, 2020, 22 : 40 - 40
  • [2] Randomized Phase II and Biomarker Study of Pembrolizumab plus Bevacizumab versus Pembrolizumab Alone for Patients with Recurrent Glioblastoma
    Nayak, Lakshmi
    Molinaro, Annette M.
    Peters, Katherine
    Clarke, Jennifer L.
    Jordan, Justin T.
    de Groot, John
    Nghiemphu, Leia
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Gaffey, Sarah
    Smith, Timothy R.
    Cote, David J.
    Severgnini, Mariano
    Yearley, Jennifer H.
    Zhao, Qing
    Blumenschein, Wendy M.
    Duda, Dan G.
    Muzikansky, Alona
    Jain, Rakesh K.
    Wen, Patrick Y.
    Reardon, David A.
    CLINICAL CANCER RESEARCH, 2021, 27 (04) : 1048 - 1057
  • [3] Safety of pembrolizumab in combination with bevacizumab in recurrent glioblastoma (rGBM).
    Reardon, David A.
    De Groot, John Frederick
    Colman, Howard
    Jordan, Justin T.
    Daras, Mariza
    Clarke, Jennifer Leigh
    Nghiemphu, Phioanh Leia
    Gaffey, Sarah C.
    Peters, Katherine B.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] NEUROLOGIC ASSESSMENT IN NEURO-ONCOLOGY (NANO) SCALE IN A PHASE II STUDY OF PEMBROLIZUMAB OR PEMBROLIZUMAB PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Nayak, Lakshmi
    Molinaro, Annette
    Peters, Katherine
    Clarke, Jennifer
    Jordan, Justin
    de Groot, John
    Nghiemphu, Phioanh
    Kaley, Thomas
    Colman, Howard
    McCluskey, Christine
    Gaffey, Sarah
    Smith, Timothy
    Cote, David
    Severgnini, Mariano
    Yearley, Jennifer
    Zhao, Qing
    Blumenschein, Wendy
    Duda, Gabriel
    Muzikansky, Alona
    Jain, Rakesh
    Wen, Patrick
    Reardon, David
    NEURO-ONCOLOGY, 2020, 22 : 138 - 139
  • [5] Phase Ib study of olinvacimab (O) with pembrolizumab (P) in patients with recurrent glioblastoma (rGBM).
    Nowak, Anna K.
    Cher, Lawrence
    Bowyer, Samantha
    Gan, Hui Kong
    Long, Anne Poh
    Balasubramanian, Adithya
    Lee, Seon Young
    Lee, Weon Sup
    Yoo, Jin-San
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Re-Irradiation Plus Pembrolizumab: A Phase II Study for Patients with Recurrent Glioblastoma
    Iwamoto, Fabio M.
    Tanguturi, Shyam K.
    Nayak, Lakshmi
    Wang, Tony J.
    Desai, Arati
    Lustig, Robert A.
    Bagley, Stephen
    Wong, Eric T.
    Hertan, Lauren M.
    Mccluskey, Christine
    Hayden, Julia
    Muzikansky, Alona
    Nakhawa, Shreya
    Japo, Julia
    Bossi, Connor C.
    Meylan, Maxime
    Tian, Ye
    Barlow, Graham L.
    Speliakos, Paul
    Ayoub, Georges
    Meredith, David M.
    Ligon, Keith L.
    Haas-Kogan, Daphne
    Huang, Kun
    Wucherpfennig, Kai W.
    Wen, Patrick Y.
    Reardon, David A.
    CLINICAL CANCER RESEARCH, 2025, 31 (02) : 316 - 327
  • [7] PHASE II STUDY OF PEMBROLIZUMAB PLUS SURVAXM FOR GLIOBLASTOMA AT FIRST RECURRENCE
    Ahluwalia, Manmeet
    Peereboom, David
    Rauf, Yasmeen
    Schilero, Cathy
    Ciolfi, Marci
    Ciesielski, Michael
    Fenstermaker, Robert
    NEURO-ONCOLOGY, 2020, 22 : 34 - 35
  • [8] PHASE II STUDY OF ONARTUZUMAB PLUS BEVACIZUMAB VERSUS PLACEBO PLUS BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA
    Cloughesy, Tim
    Finocchiaro, Gaetano
    Belda-Iniesta, Cristobel
    Recht, Lawrence
    Brandes, Alba A.
    Pineda, Estela
    Mikkelsen, Tom
    Chinot, Olivier
    Balana, Carmen
    Macdonald, David
    Westphal, Manfred
    Hopkins, Kirsten
    Weller, Michael
    Bruey, Jean-Marie
    Liu, Bo
    Verret, Wendy
    NEURO-ONCOLOGY, 2014, 16
  • [9] PHASE 2 STUDY OF PD-1 BLOCKADE WITH PEMBROLIZUMAB PLUS RE-IRRADIATION FOR RECURRENT GLIOBLASTOMA (RGBM) (NCT03661723)
    Iwamoto, Fabio
    Tanguturi, Shyam
    Desai, Arati
    Nayak, Lakshmi
    Uhlmann, Erik
    Wang, Tony
    Lustig, Robert
    Hertan, Lauren
    Bagley, Stephen
    Hayden, Julia
    Laforest-Roys, Corey
    Muzikansky, Alona
    McCluskey, Christine
    Chukwueke, Ugonma
    McFaline-Figueroa, J. Ricardo
    Lee, Eudocia
    Wen, Patrick Y.
    Reardon, David
    NEURO-ONCOLOGY, 2022, 24 : 63 - 64
  • [10] Phase II study of pembrolizumab plus SurVaxM for glioblastoma at first recurrence.
    Ahluwalia, Manmeet Singh
    Peereboom, David M.
    Ciolfi, Marci
    Schilero, Cathy
    Hobbs, Brian
    Ciesielski, Michael J.
    Fenstermaker, Robert Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345